New Thai medical devices act by 2007:
This article was originally published in Clinica
Discussion on a new Thai medical devices act aimed at revising registration requirements and regulations on product liability, are ongoing between the Thai Food and Drug Administration and the medical device industry. The act, which should be in place by 2007, will also list licensing requirements for distributors and manufacturers and corresponding fees, reports the consultancy, Pacific Bridge. Following the eventual implementation of the new act by the Thai ministry of public health, existing registrations will remain in place until their initial expiry dates. However, the act must first be submitted to parliament for approval.
You may also be interested in...
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.